Skip to main content
. 2014 Sep 30;9(9):e108610. doi: 10.1371/journal.pone.0108610

Figure 2. Net cost per number of cancers prevented for different strategies for screening and treatment of H. pylori in a population with a 75% prevalence of H. pylori infection shown as an Incremental Cost Effectiveness Ratio (ICER).

Figure 2

Red line indicates lowest net cost per cancer prevented.